My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 46

    1.

    Error occurred: cannot get document summary

    PMID:
    22277911

    2.

    Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma.

    O'Dell MR, Huang JL, Whitney-Miller CL, Deshpande V, Rothberg P, Grose V, Rossi RM, Zhu AX, Land H, Bardeesy N, Hezel AF.

    Cancer Res. 2012 Mar 15;72(6):1557-67. Epub 2012 Jan 20.

    PMID:
    22266220
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.

    Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel W, Fang HB, Vafai SB, Vazquez F, Puigserver P, Boros L, Girnun GD.

    Cancer Res. 2011 Nov 1;71(21):6888-98. Epub 2011 Sep 13.

    PMID:
    21914785
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.

    Liu F, Liu Q, Yang D, Bollag WB, Robertson K, Wu P, Liu K.

    Cancer Res. 2011 Nov 1;71(21):6807-16. Epub 2011 Sep 12.

    PMID:
    21911457
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Autophagy enhanced by microtubule- and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis.

    Xie R, Wang F, McKeehan WL, Liu L.

    Cancer Res. 2011 Dec 15;71(24):7537-46. Epub 2011 Oct 28.

    PMID:
    22037873
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    miR-221 silencing blocks hepatocellular carcinoma and promotes survival.

    Park JK, Kogure T, Nuovo GJ, Jiang J, He L, Kim JH, Phelps MA, Papenfuss TL, Croce CM, Patel T, Schmittgen TD.

    Cancer Res. 2011 Dec 15;71(24):7608-16. Epub 2011 Oct 18.

    PMID:
    22009537
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    p53 negatively regulates the hepatoma growth factor HDGF.

    Sasaki Y, Negishi H, Idogawa M, Yokota I, Koyama R, Kusano M, Suzuki H, Fujita M, Maruyama R, Toyota M, Saito T, Tokino T.

    Cancer Res. 2011 Nov 15;71(22):7038-47. Epub 2011 Oct 17.

    PMID:
    22006999
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Asialoglycoprotein receptor promotes cancer metastasis by activating the EGFR-ERK pathway.

    Ueno S, Mojic M, Ohashi Y, Higashi N, Hayakawa Y, Irimura T.

    Cancer Res. 2011 Oct 15;71(20):6419-27. Epub 2011 Aug 25.

    PMID:
    21868757
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.

    Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, Miyano S, Mori M.

    Cancer Res. 2011 Oct 15;71(20):6320-6. Epub 2011 Aug 23. Erratum in: Cancer Res. 2012 Feb 15;72(4):1039.

    PMID:
    21862635
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.

    Wu YM, Liu CH, Hu RH, Huang MJ, Lee JJ, Chen CH, Huang J, Lai HS, Lee PH, Hsu WM, Huang HC, Huang MC.

    Cancer Res. 2011 Dec 1;71(23):7270-9. Epub 2011 Oct 11.

    PMID:
    21990321
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8.

    Lee EK, Kim DG, Kim JS, Yoon Y.

    Cancer Res. 2011 Nov 1;71(21):6827-35. Epub 2011 Sep 14.

    PMID:
    21917729
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.

    Patterson AD, Maurhofer O, Beyoglu D, Lanz C, Krausz KW, Pabst T, Gonzalez FJ, Dufour JF, Idle JR.

    Cancer Res. 2011 Nov 1;71(21):6590-600. Epub 2011 Sep 7.

    PMID:
    21900402
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Definition of the landscape of promoter DNA hypomethylation in liver cancer.

    Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, Szyf M.

    Cancer Res. 2011 Sep 1;71(17):5891-903. Epub 2011 Jul 11.

    PMID:
    21747116
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy.

    Halama N, Michel S, Kloor M, Zoernig I, Benner A, Spille A, Pommerencke T, von Knebel DM, Folprecht G, Luber B, Feyen N, Martens UM, Beckhove P, Gnjatic S, Schirmacher P, Herpel E, Weitz J, Grabe N, Jaeger D.

    Cancer Res. 2011 Sep 1;71(17):5670-7. Epub 2011 Aug 16.

    PMID:
    21846824
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Comparing signaling networks between normal and transformed hepatocytes using discrete logical models.

    Saez-Rodriguez J, Alexopoulos LG, Zhang M, Morris MK, Lauffenburger DA, Sorger PK.

    Cancer Res. 2011 Aug 15;71(16):5400-11. Epub 2011 Jul 8.

    PMID:
    21742771
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.

    Lei F, Zhao B, Haque R, Xiong X, Budgeon L, Christensen ND, Wu Y, Song J.

    Cancer Res. 2011 Jul 15;71(14):4742-7. Epub 2011 May 31.

    PMID:
    21628492
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Association of specific genotypes in metastatic suppressor HTPAP with tumor metastasis and clinical prognosis in hepatocellular carcinoma.

    Ren N, Wu JC, Dong QZ, Sun HJ, Jia HL, Li GC, Sun BS, Dai C, Shi J, Wei JW, Sheng YY, Zhou HJ, Ye QH, Qin LX.

    Cancer Res. 2011 May 1;71(9):3278-86. Erratum in: Cancer Res. 2011 Jun 15;71(12):4325.

    PMID:
    21531764
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    18.

    Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis.

    Voisin T, El Firar A, Fasseu M, Rouyer-Fessard C, Descatoire V, Walker F, Paradis V, Bedossa P, Henin D, Lehy T, Laburthe M.

    Cancer Res. 2011 May 1;71(9):3341-51. Epub 2011 Mar 17.

    PMID:
    21415167
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    19.

    Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.

    Chen J, Zhang B, Wong N, Lo AW, To KF, Chan AW, Ng MH, Ho CY, Cheng SH, Lai PB, Yu J, Ng HK, Ling MT, Huang AL, Cai XF, Ko BC.

    Cancer Res. 2011 Jun 15;71(12):4138-49. Epub 2011 Apr 28. Erratum in: Cancer Res. 2012 Feb 15;72(4):1038.

    PMID:
    21527554
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Chronic inflammatory IFN-γ signaling suppresses hepatocarcinogenesis in mice by sensitizing hepatocytes for apoptosis.

    Lüth S, Schrader J, Zander S, Carambia A, Buchkremer J, Huber S, Reifenberg K, Yamamura K, Schirmacher P, Lohse AW, Herkel J.

    Cancer Res. 2011 Jun 1;71(11):3763-71. Epub 2011 Apr 21.

    PMID:
    21512142
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk